Thiogenesis Therapeutics Corp (TTI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,970 | 5,524 | 7,076 | 3,632 | 4,643 |
| Receivables | 48 | 96 | 85 | 45 | 47 |
| TOTAL | $5,064 | $5,688 | $7,243 | $3,686 | $4,699 |
| Non-Current Assets | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $5,064 | $5,688 | $7,243 | $3,686 | $4,699 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $308 | $345 | $1,713 | $320 | $350 |
| Non-Current Liabilities | |||||
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $308 | $345 | $1,713 | $320 | $350 |
| Shareholders' Equity | |||||
| Common Shares | 15,657 | 15,657 | 15,010 | 11,128 | 11,128 |
| Retained earnings | -12,500 | -11,849 | -11,138 | -9,169 | -8,115 |
| Other shareholders' equity | 1,599 | 1,535 | 1,658 | 1,407 | 1,335 |
| TOTAL | $4,756 | $5,343 | $5,530 | $3,366 | $4,349 |
| Total Liabilities And Equity | $5,064 | $5,688 | $7,243 | $3,686 | $4,699 |